Key facts
- Galen Health’s last known valuation is $330K (Mar 2025).
- It has raised $20K; the latest was Early Stage VC in Apr 2026.
- Notable investors include Techstars, Ollin Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Galen Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Galen Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Galen Health
Developer of AI-based health technology designed to improve early cancer detection. The company's technology specializes in computational medicine, offering products with an AI-powered early detection system for pancreatic cancer and a technology that identifies high-risk individuals at early stages, enabling healthcare providers to intervene sooner and significantly increase survival rates for at-risk patients.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2024
- Website
- galenhealth.org/
- Ownership
- Privately Held (backing)
Galen Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Galen Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Galen Health in its N-PORT filings yet. We sweep new filings monthly.